OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Review article: The role of the gut–brain axis in inflammatory bowel disease and its therapeutic implications
Christy Riggott, Alexander C. Ford, David J. Gracie
Alimentary Pharmacology & Therapeutics (2024) Vol. 60, Iss. 9, pp. 1200-1214
Closed Access | Times Cited: 13
Christy Riggott, Alexander C. Ford, David J. Gracie
Alimentary Pharmacology & Therapeutics (2024) Vol. 60, Iss. 9, pp. 1200-1214
Closed Access | Times Cited: 13
Showing 13 citing articles:
Review article: Measuring disease severity in inflammatory bowel disease – Beyond treat to target
Akhilesh Swaminathan, Andrew S. Day, Miles Sparrow, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 60, Iss. 9, pp. 1176-1199
Open Access | Times Cited: 10
Akhilesh Swaminathan, Andrew S. Day, Miles Sparrow, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 60, Iss. 9, pp. 1176-1199
Open Access | Times Cited: 10
Review article: Evidence‐based dietary management of inflammatory bowel disease
Peter R. Gibson, Chu K Yao, Emma P. Halmos
Alimentary Pharmacology & Therapeutics (2024) Vol. 60, Iss. 9, pp. 1215-1233
Open Access | Times Cited: 9
Peter R. Gibson, Chu K Yao, Emma P. Halmos
Alimentary Pharmacology & Therapeutics (2024) Vol. 60, Iss. 9, pp. 1215-1233
Open Access | Times Cited: 9
Review article: Prevention of inflammatory bowel disease—The path forward
Sérgio Bronze, Manasi Agrawal, Jean‐Frédéric Colombel, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 60, Iss. 9, pp. 1166-1175
Closed Access | Times Cited: 9
Sérgio Bronze, Manasi Agrawal, Jean‐Frédéric Colombel, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 60, Iss. 9, pp. 1166-1175
Closed Access | Times Cited: 9
Review article: Novel therapies in inflammatory bowel disease – An update for clinicians
Nurulamin M Noor, Alice Bourke, Sreedhar Subramanian
Alimentary Pharmacology & Therapeutics (2024) Vol. 60, Iss. 9, pp. 1244-1260
Open Access | Times Cited: 9
Nurulamin M Noor, Alice Bourke, Sreedhar Subramanian
Alimentary Pharmacology & Therapeutics (2024) Vol. 60, Iss. 9, pp. 1244-1260
Open Access | Times Cited: 9
Review article: Optimisation of biologic (monoclonal antibody) therapeutic response in inflammatory bowel disease
Thanaboon Chaemsupaphan, Rupert W. Leong, Niels Vande Casteele, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 60, Iss. 9, pp. 1234-1243
Open Access | Times Cited: 8
Thanaboon Chaemsupaphan, Rupert W. Leong, Niels Vande Casteele, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 60, Iss. 9, pp. 1234-1243
Open Access | Times Cited: 8
Current Advances in the Therapeutic Potential of Scutellarin: Novel Applications, Mechanisms, and Future Challenges.
Great Iruoghene Edo, Alice Njolke Mafe, Patrick Othuke Akpoghelie, et al.
Phytomedicine Plus (2025), pp. 100754-100754
Open Access
Great Iruoghene Edo, Alice Njolke Mafe, Patrick Othuke Akpoghelie, et al.
Phytomedicine Plus (2025), pp. 100754-100754
Open Access
Therapeutic potential of tryptophan metabolite indoleacrylic acid in inflammatory bowel disease: From cellular mechanisms to zebrafish stress-like behavior
R. P. G. S. K. Amarasiri, Jimin Hyun, Sang-Woon Lee, et al.
International Immunopharmacology (2025) Vol. 149, pp. 114207-114207
Closed Access
R. P. G. S. K. Amarasiri, Jimin Hyun, Sang-Woon Lee, et al.
International Immunopharmacology (2025) Vol. 149, pp. 114207-114207
Closed Access
Effects of psychological stress on inflammatory bowel disease via affecting the microbiota–gut–brain axis
Yuhan Chen, Xiaofeng Chen, Sheng‐Hao Lin, et al.
Chinese Medical Journal (2025)
Open Access
Yuhan Chen, Xiaofeng Chen, Sheng‐Hao Lin, et al.
Chinese Medical Journal (2025)
Open Access
Inflammatory bowel disease in 2024 and beyond
Richard B. Gearry, Cynthia H. Seow, Sreedhar Subramanian
Alimentary Pharmacology & Therapeutics (2024) Vol. 60, Iss. 9, pp. 1164-1165
Open Access
Richard B. Gearry, Cynthia H. Seow, Sreedhar Subramanian
Alimentary Pharmacology & Therapeutics (2024) Vol. 60, Iss. 9, pp. 1164-1165
Open Access
Pathophysiological, Neuropsychological, and Psychosocial Influences on Neurological and Neuropsychiatric Symptoms of Post-Acute COVID-19 Syndrome: Impacts on Recovery and Symptom Persistence
Alex Malioukis, R Sterling Snead, Julia Marczika, et al.
Biomedicines (2024) Vol. 12, Iss. 12, pp. 2831-2831
Open Access
Alex Malioukis, R Sterling Snead, Julia Marczika, et al.
Biomedicines (2024) Vol. 12, Iss. 12, pp. 2831-2831
Open Access
Efficacy and Safety of a Mixture of Microencapsulated Sodium Butyrate, Probiotics, and Short Chain Fructooligosaccharides in Patients with Irritable Bowel Syndrome—A Randomized, Double-Blind, Placebo-Controlled Study
Anita Gąsiorowska, Marek Romanowski, Ewa Walecka‐Kapica, et al.
Journal of Clinical Medicine (2024) Vol. 14, Iss. 1, pp. 6-6
Open Access
Anita Gąsiorowska, Marek Romanowski, Ewa Walecka‐Kapica, et al.
Journal of Clinical Medicine (2024) Vol. 14, Iss. 1, pp. 6-6
Open Access
Editorial: Understanding Factors Associated With Abdominal Pain in Ulcerative Colitis—No Surprises but the Usual Suspects Need Greater Attention. Authors' Reply
Tom van Gils, Hans Törnblom, Jóhann P. Hreinsson, et al.
Alimentary Pharmacology & Therapeutics (2024)
Open Access
Tom van Gils, Hans Törnblom, Jóhann P. Hreinsson, et al.
Alimentary Pharmacology & Therapeutics (2024)
Open Access
Letter: Integrating Psychological Profiles Into Dietary Interventions for IBS —Commentary on HADS Scores and Treatment Efficacy
Chia‐Wei Chen, Lien‐Chung Wei
Alimentary Pharmacology & Therapeutics (2024)
Closed Access
Chia‐Wei Chen, Lien‐Chung Wei
Alimentary Pharmacology & Therapeutics (2024)
Closed Access
